Literature DB >> 28795273

Capacity of gold nanoparticles in cancer radiotherapy.

Nadeem M S Nagi1, Yasir A M Khair1, Ahmed M E Abdalla2.   

Abstract

Radiotherapy is the ionizing radiation used for treatment of cancer and other diseases. Although radiotherapy is the major treatment for cancer, a lot of patients do not undergo radiation due to associated risks such as radiation pneumonitis, cardiovascular complications, development of secondary tumor, and lymphedema. However, the advantages of nanotechnology provide a unique potential to enhance radiotherapeutic performance, in particular by utilizing gold nanoparticles (Au NPs). In this review, we briefly describe the current direction of research towards the use of Au NPs for radiotherapeutic enhancement, combination, monitoring and in side effect reductions.

Entities:  

Keywords:  Cancer radiotherapy; Drug resistance; Gold nanoparticles; Radio-sensitizer

Mesh:

Substances:

Year:  2017        PMID: 28795273     DOI: 10.1007/s11604-017-0671-6

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  53 in total

Review 1.  Physical basis and biological mechanisms of gold nanoparticle radiosensitization.

Authors:  Karl T Butterworth; Stephen J McMahon; Fred J Currell; Kevin M Prise
Journal:  Nanoscale       Date:  2012-07-06       Impact factor: 7.790

Review 2.  Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles.

Authors:  Rui Hao; Ruijun Xing; Zhichuan Xu; Yanglong Hou; Song Gao; Shouheng Sun
Journal:  Adv Mater       Date:  2010-07-06       Impact factor: 30.849

Review 3.  Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.

Authors:  Jing Zhao; Si-Shen Feng
Journal:  Nanomedicine (Lond)       Date:  2015-07       Impact factor: 5.307

Review 4.  DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems.

Authors:  B Halliwell; O I Aruoma
Journal:  FEBS Lett       Date:  1991-04-09       Impact factor: 4.124

Review 5.  Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.

Authors:  Feng Jia; Xunpei Liu; Linheng Li; Surya Mallapragada; Balaji Narasimhan; Qun Wang
Journal:  J Control Release       Date:  2013-10-17       Impact factor: 9.776

Review 6.  Gold nanoparticles in biomedical applications: recent advances and perspectives.

Authors:  Lev Dykman; Nikolai Khlebtsov
Journal:  Chem Soc Rev       Date:  2011-11-30       Impact factor: 54.564

Review 7.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

Review 8.  Engineered nanoparticles in cancer therapy.

Authors:  Natalie P Praetorius; Tarun K Mandal
Journal:  Recent Pat Drug Deliv Formul       Date:  2007

9.  Doxorubicin/gold-loaded core/shell nanoparticles for combination therapy to treat cancer through the enhanced tumor targeting.

Authors:  Kyungim Kim; Keun Sang Oh; Dal Yong Park; Jae Young Lee; Beom Suk Lee; In San Kim; Kwangmeyung Kim; Ick Chan Kwon; Yoon Kim Sang; Soon Hong Yuk
Journal:  J Control Release       Date:  2016-03-10       Impact factor: 9.776

Review 10.  The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Authors:  Josep M Llovet; Josep Fuster; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

View more
  3 in total

1.  Radiosensitization effects by bismuth oxide nanorods of different sizes in megavoltage external beam radiotherapy.

Authors:  Amirah Jamil; Safri Zainal Abidin; Khairunisak Abdul Razak; Hafiz Zin; Muhammad Amir Yunus; Wan Nordiana Rahman
Journal:  Rep Pract Oncol Radiother       Date:  2021-09-30

Review 2.  Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy.

Authors:  Yao Chen; Juan Yang; Shaozhi Fu; Jingbo Wu
Journal:  Int J Nanomedicine       Date:  2020-11-24

Review 3.  Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications.

Authors:  Francis Boateng; Wilfred Ngwa
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.